Skip to Main Content

Author Details

Hao Fan
College of Biotechnology and Bioengineering, Zhejiang University of Technology
2001
38
22
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33095579Structure-Activity Relationships of Noncovalent Immunoproteasome β5i-Selective Dipeptides.J Med Chem2020
31421725A novel self-sufficient biocatalyst based on transaminase and pyridoxal 5'-phosphate covalent co-immobilization and its application in continuous biosynthesis of sitagliptin.Enzyme Microb Technol2019
29967165Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance.Proc Natl Acad Sci U S A2018
27976853Structural Basis for the Species-Selective Binding of N,C-Capped Dipeptides to the Mycobacterium tuberculosis Proteasome.Biochemistry2017
29167449Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes.Nat Commun2017
27561172Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.ChemMedChem2016
27956634Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice.Proc Natl Acad Sci U S A2016
26443011Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking.J Med Chem2015
24271400ModBase, a database of annotated comparative protein structure models and associated resources.Nucleic Acids Res2014
24802635Prediction of substrates for glutathione transferases by covalent docking.J Chem Inf Model2014
24900849Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome.ACS Med Chem Lett2014
23256477Assignment of pterin deaminase activity to an enzyme of unknown function guided by homology modeling and docking.J Am Chem Soc2013
24078704Optimized atomic statistical potentials: assessment of protein interfaces and loops.Bioinformatics2013
23972005Deamination of 6-aminodeoxyfutalosine in menaquinone biosynthesis by distantly related enzymes.Biochemistry2013
23968233Structure-guided discovery of new deaminase enzymes.J Am Chem Soc2013
23509259Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1.Proc Natl Acad Sci U S A2013
22183533Virtual ligand screening against comparative protein structure models.Methods Mol Biol2012
22932902High selectivity of the γ-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approach.J Biol Chem2012
22411697Mimicking the action of folding chaperones by Hamiltonian replica-exchange molecular dynamics simulations: application in the refinement of de novo models.Proteins2012
21275375Enzymatic deamination of the epigenetic base N-6-methyladenine.J Am Chem Soc2011
22014038Statistical potential for modeling and ranking of protein-ligand interactions.J Chem Inf Model2011
21823622Discovery of a cytokinin deaminase.ACS Chem Biol2011
21885739Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET.Proc Natl Acad Sci U S A2011
21926995Ligand discovery from a dopamine D3 receptor homology model and crystal structure.Nat Chem Biol2011
21247091Catalytic mechanism and three-dimensional structure of adenine deaminase.Biochemistry2011
19845314Molecular docking screens using comparative models of proteins.J Chem Inf Model2009
18338384Refining homology models by combining replica-exchange molecular dynamics and statistical potentials.Proteins2008
19180249Vulnerability in Popular Molecular Dynamics Packages Concerning Langevin and Andersen Dynamics.J Chem Theory Comput2008
17489626How sensitive are nanosecond molecular dynamics simulations of proteins to changes in the force field?J Phys Chem B2007
16452612Mimicking the action of GroEL in molecular dynamics simulations: application to the refinement of protein structures.Protein Sci2006
16770796Molecular dynamics simulations of the hydrophobin SC3 at a hydrophobic/hydrophilic interface.Proteins2006
15814616Comparative study of generalized Born models: protein dynamics.Proc Natl Acad Sci U S A2005
16213522The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.J Mol Biol2005
14691236Refinement of homology-based protein structures by molecular dynamics simulation techniques.Protein Sci2004
15010545Mimicking the action of folding chaperones in molecular dynamics simulations: Application to the refinement of homology-based protein structures.Protein Sci2004
12945054Relative stability of protein structures determined by X-ray crystallography or NMR spectroscopy: a molecular dynamics simulation study.Proteins2003
11394738Design of new selective inhibitors of cyclooxygenase-2 by dynamic assembly of molecular building blocks.J Comput Aided Mol Des2001
11989626Structure-based ligand design for flexible proteins: application of new F-DycoBlock.J Comput Aided Mol Des2001
  • 1 - 38 of 38

Recommended Authors

Michigan State University
Career Start Year 2011
Number of shared co-authors 2
University of California
Career Start Year 2001
Number of shared co-authors 2
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 2
Stanford University
Career Start Year 1999
Number of shared co-authors 2
Pennsylvania State University College of Medicine
Career Start Year 1998
Number of shared co-authors 4
Diamond Light Source Ltd, Harwell Science & Innovation Campus
Career Start Year 1998
Number of shared co-authors 4
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 5
Indian Institute of Science Education and Research Pune
Career Start Year 1996
Number of shared co-authors 7
Weizmann Institute of Science
Career Start Year 1995
Number of shared co-authors 6
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1993
Number of shared co-authors 0
Bijvoet Center for Biomolecular Research, Utrecht University
Career Start Year 1991
Number of shared co-authors 6
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 3
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year 1990
Number of shared co-authors 3
Center for Molecular Biology (ZMBH), Heidelberg University
Career Start Year 1989
Number of shared co-authors 5
University of Virginia
Career Start Year 1989
Number of shared co-authors 8
The Francis Crick Institute
Career Start Year 1989
Number of shared co-authors 3
Fox Chase Cancer Center
Career Start Year 1989
Number of shared co-authors 6
Weizmann Institute of Science
Career Start Year 1988
Number of shared co-authors 3
University of Washington
Career Start Year 1988
Number of shared co-authors 10
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 2
Sanford-Burnham-Prebys Medical Discovery Institute
Career Start Year 1987
Number of shared co-authors 1
Boston University
Career Start Year 1987
Number of shared co-authors 2
Cambridge Institute for Medical Research, University of Cambridge
Career Start Year 1982
Number of shared co-authors 3
Boston University
Career Start Year 1982
Number of shared co-authors 6
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 4
Institute for Protein Research, Osaka University
Career Start Year 1980
Number of shared co-authors 5
University of Michigan ann arbor
Career Start Year 1974
Number of shared co-authors 3
Stanford University
Career Start Year 1969
Number of shared co-authors 4
Albert Einstein College of Medicine
Career Start Year 1968
Number of shared co-authors 17
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 5

Collaborators

University of California San Francisco
Co-authored papers 17
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 10
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 6
Texas A&M University, College Station
Co-authored papers 6
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 4
University of California san francisco
Co-authored papers 4
Co-authored papers 4
University of California San Francisco
Co-authored papers 3
Albert Einstein College of Medicine
Co-authored papers 3
The Hebrew University of Jerusalem
Co-authored papers 3
Cue BioPharma Inc.
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Albert Einstein College of Medicine
Co-authored papers 3
The State University of New Jersey
Co-authored papers 2
Brookhaven National Laboratory
Co-authored papers 2
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 2
Stanford University
Co-authored papers 2
Eli Lilly and Co.
Co-authored papers 2
Columbia University Irving Medical Center
Co-authored papers 2
University of Science & Technology of China
Co-authored papers 2
Indian Institute of Science Education and Research Pune
Co-authored papers 2
Texas A&M University , College Station
Co-authored papers 2
Brookhaven National Laboratory
Co-authored papers 1
University of California san francisco
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Medical College of Wisconsin
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
The Weizmann Institute of Science
Co-authored papers 1